The aim of this study was to investigate the effect of apelin (one of adipokine) 
INTRODUCTION
The endothelium plays a central role in the maintenance of vascular homeostasis. One of the main effectors of endothelial dysfunction is angiotensin II (Ang II) and pharmacological approaches to limit AngII bioactivity remain the corner stone of cardiovascular therapeutics (1) . AngII promotes generation of oxidative stress in the vasculature which appears to be a key mediator of AngII induced endothelial dysfunction, endothelial cell apoptosis and lipoprotein peroxidation (2) . Losartan is a specific angiotensin-1 receptor (AT-1) antagonist which can effectively inhibit the effect of AngII. However, the effect of losartan on atherosclerosis has been rarely demonstrated (3) . Adipocytokines secreted by adipose tissue have an important role in inflammation which is considered to be a crucial pathogenic factor of atherosclerosis (4) . Apelin a relatively newer adipokine with various actions on cardiovascular system causing dyslipidemia (5) . Apelin is expressed primarily in the endothelium and act both locally and via endocrine signaling to activate cognate G protein coupled receptor (orphan receptor APJ), which is expressed on myocardial cells, endothelial cells and some smooth muscle cells (6) . Apelin has been shown to have a positive effect on contractility and in the vasculature.
(7)
Other studies support a vasodepressor role in both the arterial and venous circulation and supposed that these effects are mediated at least in part by nitric oxide (8) . These data suggest that the vascular action of apelin may be complex and involve effects in addition to eNOS activation depending on the apelin dose, species and other experimental factors. Apelin is identified as AngII homologue which counteracts the actions of AngII. In addition, there is a sequence homology between apelin and AT1 receptors and the anatomical distribution of both receptors and peptides overlap in the cardiovascular system (9) . However, the functional effects of apelin are independent of AT1 receptor and APJ receptors do not show specific binding of AngII (10) . The aim of the present work is to study the effect of losartan as an AT-1 receptor blocker or apelin and its APJ system on atherosclerosis produced by high cholesterol diet and treated by injection of AngII in rats.
MATERIAL & METHODS
This study was carried out on forty male albino rat, collected randomly weighing 205+18g body weight. These animals were housed under 12 hours day/night cycle at room temperature. 
Statistical analysis:
Data were presented as a mean value +SD and analysis of the results using one way ANOVA differences between individual groups were determined with the Scheffe test. Results were considered significant at P<0.05 using SPSS computer program version 16. Tumor necrotic factor alpha is significantly increased after high cholesterol diet alone or together with AngII , while treatment with losartan or apelin with AngII showed significant decrease P<0.05 table & Fig. (2) .
RESULTS
Also, as shown in table (2) there is a significant decrease in NO after saline or AngII in high cholesterol diet fed rats as compared to normal fed group P<0.05 and it increased significantly after losartan or apelin treatment Fig (3) .
Concerning C-reactive protein it is significantly increased after saline and AngII injection but significantly decreased after treatment with losartan or apelin Fig. ( 
DISCUSSION
In the fact of existing data suggesting a prominent role of AngII in mediating atherosclerosis in hypercholesterolemic rats since it promotes generation of oxidative stress in the vasculature, which appears to be a key mediator of AngII induced endothelial dysfunction (2) . AngII exerts direct effects on the arterial wall to influence atherosclerosis with the induction of vascular inflammation (22) . AngII is known to accelerate the progression of macrophage-driven atherosclerotic lesions.
Acyl reported that activation of apelin receptors caused release of nitric oxide which inhibited angiotensin II induced rise in intracellular calcium.
Our results agree with Erdem et al.
(41) as dysregulation of apelin might be involved in the mechanism of establishment of diabetes associated with atherosclerosis.
There is some evidence for direct counter regulation of the rennin angiotensin system by apelin APJ (42) and it appears from other works that AngII increases vascular tone and raises blood pressure. Apelin is a vasodilator and lower blood pressure AngII and apelin are expressed in functionally apposing neurons in the hypothalamus and AngII promotes vasopressin release while apelin inhibits its release. Also glucocorticoids increase AngII levels and suppress apelin expression (43) .
Conclusion:
The present data establish that apelin can block a number of AngII related pathological processes associated with atherosclerosis on effect similar to that of AT-1 blocker (losartan). This inhibitory activity is likely mediated by increased endothelial NO production. These data suggest a role for the apelin APJ pathway in atherosclerosis and AngII mediated vascular remodeling and provide directions for additional studies and further investigations for the mechanisms of the observed effects.
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